Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
基本信息
- 批准号:9265416
- 负责人:
- 金额:$ 36.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-13 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAddressAffectAtlasesBindingC-terminalCBFA2T1 geneCancer ModelCanesChimeric ProteinsChromatinChromosomal translocationChromosomes, Human, Pair 16Chromosomes, Human, Pair 8Colon CarcinomaComplexDNA Binding DomainDNA MethylationDNA Polymerase IIDataDevelopmentE proteinElongation FactorEnzymesEventFamily memberGene ActivationGene ExpressionGene ProteinsGenesGeneticGenetic TranscriptionGenomeHistone DeacetylaseHodgkin DiseaseImpairmentLengthLinkMLL geneMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of ovaryModelingMusMutateMutationMyelogenousN-terminalNCOR1 genePhenotypePhysiologicalPoint MutationProteomicsRNARNA SplicingRUNX1 geneRecruitment ActivityRegulationRoleSolid NeoplasmTAL1 geneTCF3 geneTestingThe Cancer Genome AtlasTranscription ElongationTranscriptional Elongation FactorsTranscriptional RegulationTumor SuppressionVariantWorkYeastsexperimental studygene repressiongene translocationglobal run on sequencinghistone methyltransferasein vivoinnovationleukemialeukemogenesismalignant breast neoplasmmouse modelmutantnovelnovel strategiesprotein Epublic health relevancerelease factort(821)(q22q22)transcription factortumortumorigenesisyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Two myeloid translocation gene (MTG) family members, MTG8 and MTG16 are disrupted by chromosomal translocations in acute myeloid leukemia. In addition, the caner genome atlas (TCGA) and other large sequencing studies have identified mutations in MTG family members that are scattered throughout the gene body, suggesting that these may be inactivating mutations. Consistent with this interpretation, MTG16 is affected by DNA methylation in Hodgkin's lymphoma and MTG16 and MTGR1 are under expressed in colon cancer. Our preliminary data support this hypothesis in that inactivating mutations accelerated tumorigenesis in three separate mouse models of cancer. Mechanistically, MTG family members have been tangentially linked to transcriptional control at the level of RNA Pol II pausing and elongation through associations with CDK9 and Tif1 (or "Moonshine"). Our preliminary data shows that MTG family members make direct contacts with key regulators of the transcriptional elongation machinery to negatively regulate gene expression. Importantly, cancer associated mutations of MTG family members affect these contacts with elongation factors. Thus, we hypothesize that MTG-dependent regulation of transcriptional pausing/elongation is a key event in tumor suppression and that release of this negative regulation allows activation of genes controlled by transcriptional pausing. By defining the mechanism by which MTGs regulate transcriptional elongation using genetics and innovative new approaches such as global run on transcription sequencing, and by using mouse models of tumorigenesis, we will directly test this hypothesis and define how loss of transcriptional control at the level of pausing and elongation contributes to tumor development.
描述(由申请人提供):两个髓系易位基因(MTG)家族成员MTG8和MTG16在急性髓系白血病中因染色体易位而被破坏。此外,癌症基因组图谱(TCGA)和其他大型测序研究已经发现MTG家族成员的突变分散在整个基因体中,表明这些可能是失活突变。与这一解释一致,MTG16 在霍奇金淋巴瘤中受到 DNA 甲基化的影响,而 MTG16 和 MTGR1 在结肠癌中表达不足。我们的初步数据支持这一假设,因为失活突变加速了三种不同小鼠癌症模型的肿瘤发生。从机制上讲,MTG 家族成员通过与 CDK9 和 Tif1(或“Moonshine”)的关联,与 RNA Pol II 暂停和延伸水平的转录控制相关。我们的初步数据表明,MTG 家族成员与转录延伸机制的关键调节因子直接接触,从而负向调节基因表达。重要的是,MTG 家族成员的癌症相关突变会影响这些与伸长因子的接触。因此,我们假设转录暂停/延伸的 MTG 依赖性调节是肿瘤抑制的关键事件,并且这种负调节的释放允许激活由转录暂停控制的基因。通过使用遗传学和创新的新方法(例如全局转录测序)来定义 MTG 调节转录延伸的机制,并使用肿瘤发生的小鼠模型,我们将直接检验这一假设并定义在暂停水平上转录控制的丧失是如何发生的。伸长有助于肿瘤的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT W HIEBERT其他文献
SCOTT W HIEBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT W HIEBERT', 18)}}的其他基金
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10298288 - 财政年份:2021
- 资助金额:
$ 36.4万 - 项目类别:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10445091 - 财政年份:2021
- 资助金额:
$ 36.4万 - 项目类别:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10298288 - 财政年份:2021
- 资助金额:
$ 36.4万 - 项目类别:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10652591 - 财政年份:2021
- 资助金额:
$ 36.4万 - 项目类别:
Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
- 批准号:
8696545 - 财政年份:2014
- 资助金额:
$ 36.4万 - 项目类别:
Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
- 批准号:
9055662 - 财政年份:2014
- 资助金额:
$ 36.4万 - 项目类别:
FASEB SRC on HDACs, Sirtuins and Reversible Acetylation in Signaling and Disease
FASEB SRC 关于 HDAC、Sirtuins 以及信号传导和疾病中的可逆乙酰化
- 批准号:
8595760 - 财政年份:2013
- 资助金额:
$ 36.4万 - 项目类别:
Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma
确定 Hdac3 是 B 细胞淋巴瘤亚型的治疗靶点
- 批准号:
10162514 - 财政年份:2012
- 资助金额:
$ 36.4万 - 项目类别:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
Hdac3 作为 BCL6 依赖性淋巴瘤的治疗靶点
- 批准号:
8431792 - 财政年份:2012
- 资助金额:
$ 36.4万 - 项目类别:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
Hdac3 作为 BCL6 依赖性淋巴瘤的治疗靶点
- 批准号:
8791883 - 财政年份:2012
- 资助金额:
$ 36.4万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 36.4万 - 项目类别:
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 36.4万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 36.4万 - 项目类别:
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantation
干细胞移植后骨髓增生异常综合征线粒体遗传的预后意义
- 批准号:
10662946 - 财政年份:2023
- 资助金额:
$ 36.4万 - 项目类别:
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantation
干细胞移植后骨髓增生异常综合征线粒体遗传的预后意义
- 批准号:
10662946 - 财政年份:2023
- 资助金额:
$ 36.4万 - 项目类别: